Core Viewpoint - The stock of Hema Technology Co., Ltd. (禾迈股份) experienced a 5.36% increase on February 3, with a trading volume of 224 million yuan and a market capitalization of 13.257 billion yuan [1] Group 1: Company Overview - Hema Technology specializes in the research, development, manufacturing, and sales of photovoltaic inverters, energy storage products, and electrical equipment [2][7] - The company's main products include micro-inverters, monitoring devices, distributed photovoltaic power generation systems, modular inverters, and energy storage systems [2][7] - Hema Technology has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and innovation capabilities [2] Group 2: Financial Performance - For the period from January to September 2025, Hema Technology reported a revenue of 1.323 billion yuan, representing a year-on-year growth of 4.57% [8] - The company recorded a net profit attributable to shareholders of -59.115 million yuan, a significant decrease of 124.07% year-on-year [8] - As of September 30, the number of shareholders increased to 10,200, with an average of 12,134 circulating shares per person, a decrease of 3.68% [8] Group 3: Market Dynamics - The company benefits from a 64.25% share of overseas revenue, aided by the depreciation of the RMB [3] - Hema Technology is set to receive an investment of no less than 111.5 million yuan and up to 223 million yuan from Hangkai Holdings Group, supported by a special loan from China CITIC Bank [3] Group 4: Technical Analysis - The average trading cost of Hema Technology's shares is 109.02 yuan, with recent trends indicating a rapid exit of shares [6] - The current stock price is near a support level of 106.60 yuan, which is critical for potential rebound or further decline [6]
禾迈股份涨5.36%,成交额2.24亿元,今日主力净流入538.29万